Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View All
AP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View All
Primary Care and Survival: Implications for Research and Policy
Published in the Journal of General Internal Medicine. Here is a link...
- About
- The Latest
- Experts